XVIVOXvivo Perfusion AB (publ)
280.00SEK+1.45%Mkt Cap: 843.64M $P/E: 99.29

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates…

Key Statistics

Company
Market Cap843.64M $
Enterprise Value814.05M $
Revenue (TTM)85.63M $
Gross Profit57.34M $
Net Income (TTM)2.41M $
Revenue/Share2.718 USD
Last Price280.00 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees197
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0004840718
Valuation
P/E (Trailing)99.29
P/E (Forward)47.21
PEG
EV/EBITDA53.77
EV/Revenue9.51
P/S9.82
P/B3.99
EPS (TTM)2.81
EPS (Forward)5.91
52W Range
160.0078% of range314.80
52W High314.80 SEK
52W Low160.00 SEK
Profitability
Gross Margin73.81%
Oper. Margin10.46%
EBITDA Margin17.68%
Profit Margin3.10%
ROE1.19%
ROA1.06%
Growth
Revenue Growth34.00%
Earnings Growth935.10%
Cash Flow & Leverage
Operating CF9.67M $
CapEx (TTM)24.19M $
FCF Margin-3.24%
FCF Yield-0.33%
Net Debt-17.54M $
Net Debt/EBITDA-1.16
Balance Sheet
Debt/Equity0.06
Current Ratio3.86
Quick Ratio2.65
Book Value/Sh69.85 SEK
Cash/Share9.682 SEK
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 SEK
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)335.60 SEK
Upside (mean)+19.9%
Target Range300.00 SEK385.00 SEK
SEK300.00+19.9% to meanSEK385.00
# Analysts5
Ownership
Shares Out.31.50M
Float25.13M
Insiders8.33%
Institutions59.29%
Technical
SMA 50264.69 (+5.8%)
SMA 200230.47 (+21.5%)
Beta1.46
S&P 52W Chg18.16%
Avg Vol (30d)71.24K
Avg Vol (10d)83.67K
Technical Indicators
RSI (14)52.1
MACD6.8278
MACD Signal6.3011
MACD Hist.+0.5267
BB Upper309.93 SEK
BB Middle270.37 SEK
BB Lower230.81 SEK
BB Width29.26%
ATR (14)11.51 SEK
Vol Ratio (20d)0.81x